Androgen biosynthesis inhibitor
This page covers all Androgen biosynthesis inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CYP17.
Targets
Marketed (1)
- Abiraterone Acetate · Pfizer · Oncology · 1500
Abiraterone is an androgen biosynthesis inhibitor that targets CYP17 to reduce androgen production in prostate cancer cells.